Next Article in Journal
Long Non-Coding RNA and Epigenetic Gene Regulation of KSHV
Next Article in Special Issue
Alpharetroviral Vectors: From a Cancer-Causing Agent to a Useful Tool for Human Gene Therapy
Previous Article in Journal
Current Perspectives on HIV-1 Antiretroviral Drug Resistance
Previous Article in Special Issue
Retroviral Vectors for Analysis of Viral Mutagenesis and Recombination
Review

Integration Site and Clonal Expansion in Human Chronic Retroviral Infection and Gene Therapy

Department of Immunology, Wright-Fleming Institute, Imperial College London, London W2 1PG, UK
*
Author to whom correspondence should be addressed.
Viruses 2014, 6(11), 4140-4164; https://doi.org/10.3390/v6114140
Received: 4 August 2014 / Revised: 9 October 2014 / Accepted: 21 October 2014 / Published: 31 October 2014
(This article belongs to the Special Issue Retroviral Vectors)
Retroviral vectors have been successfully used therapeutically to restore expression of genes in a range of single-gene diseases, including several primary immunodeficiency disorders. Although clinical trials have shown remarkable results, there have also been a number of severe adverse events involving malignant outgrowth of a transformed clonal population. This clonal expansion is influenced by the integration site profile of the viral integrase, the transgene expressed, and the effect of the viral promoters on the neighbouring host genome. Infection with the pathogenic human retrovirus HTLV-1 also causes clonal expansion of cells containing an integrated HTLV-1 provirus. Although the majority of HTLV-1-infected people remain asymptomatic, up to 5% develop an aggressive T cell malignancy. In this review we discuss recent findings on the role of the genomic integration site in determining the clonality and the potential for malignant transformation of cells carrying integrated HTLV-1 or gene therapy vectors, and how these results have contributed to the understanding of HTLV-1 pathogenesis and to improvements in gene therapy vector safety. View Full-Text
Keywords: HTLV-1; gene therapy; gammaretroviral vector; integration site HTLV-1; gene therapy; gammaretroviral vector; integration site
Show Figures

Figure 1

MDPI and ACS Style

Niederer, H.A.; Bangham, C.R.M. Integration Site and Clonal Expansion in Human Chronic Retroviral Infection and Gene Therapy. Viruses 2014, 6, 4140-4164. https://doi.org/10.3390/v6114140

AMA Style

Niederer HA, Bangham CRM. Integration Site and Clonal Expansion in Human Chronic Retroviral Infection and Gene Therapy. Viruses. 2014; 6(11):4140-4164. https://doi.org/10.3390/v6114140

Chicago/Turabian Style

Niederer, Heather A., and Charles R.M. Bangham 2014. "Integration Site and Clonal Expansion in Human Chronic Retroviral Infection and Gene Therapy" Viruses 6, no. 11: 4140-4164. https://doi.org/10.3390/v6114140

Find Other Styles

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop